Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PHSTX vs IXJ
Shared holdings
29
PHSTX covered by IXJ
61.89%
IXJ covered by PHSTX
61.89%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 43 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PHSTX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.32% | |
| JOHNSON&JOHNSON | 8.89% | |
| ABBVIE INC | 5.93% | |
| Novartis AG (Registered) | 5.52% | |
| MERCK & CO | 5.32% | |
| ASTRAZENECA PLC | 5.04% | |
| UNITEDHEALTH GRP | 4.92% | |
| INTUITIVE SURGICAL INC | 3.89% | |
| THERMO FISHER SCIENTIFIC INC | 3.70% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.90% | |
| BOSTON SCIENTIFIC CORP | 2.83% | |
| GILEAD SCIENCES INC | 2.68% | |
| MCKESSON CORP | 2.62% | |
| MEDTRONIC PLC | 2.47% | |
| Sanofi SA | 2.33% | |
| VERTEX PHARMACEUTICALS INC | 2.30% | |
| CARDINAL HEALTH INC | 2.27% | |
| BRISTOL-MYERS SQUIBB CO | 2.08% | |
| CVS HEALTH CORP | 1.84% | |
| Ascendis Pharma A/S | 1.67% | |
| EDWARDS LIFESCIENCES CORP | 1.62% | |
| HCA HEALTHCARE INC | 1.52% | |
| NOVO NORDISK-B | 1.45% | |
| Putnam Short Term Investment Fund, Class P | 1.32% | |
| ALNYLAM PHARMACEUTICALS INC | 1.31% | |
| CHUGAI PHARMA CO | 1.25% | |
| HOYA CORP | 1.24% | |
| REGENERON PHARMACEUTICALS INC | 1.23% | |
| UCB SA | 1.04% | |
| ARGENX SE | 1.01% | |
| ABBOTT LABS | 0.99% | |
| BECTON DICKINSON and CO | 0.98% | |
| GSK PLC | 0.95% | |
| VAXCYTE INC | 0.88% | |
| INSMED INC | 0.84% | |
| RHYTHM PHARMACEUTICALS INC | 0.63% | |
| US ULTRA BOND CBT Sep25 | 0.43% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.25% | |
| PRECIGEN INC | 0.22% | |
| Putnam Cash Collateral Pool LLC | 0.15% | |
| U.S. Treasury Bills | 0.12% | |
| U.S. Treasury Bills | 0.03% | |
| FX Spot Contract: EUR/USD SETTLE 2026-01-05 | 0.00% |
IXJ (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 9.42% | |
| JOHNSON&JOHNSON | 7.61% | |
| ABBVIE INC | 4.97% | |
| ASTRAZENECA PLC | 4.01% | |
| MERCK & CO | 3.95% | |
| Novartis AG (Registered) | 3.86% | |
| ROCHE HOLDING AG | 3.71% | |
| UNITEDHEALTH GRP | 3.24% | |
| AMGEN INC | 2.51% | |
| THERMO FISHER SCIENTIFIC INC | 2.44% | |
| ABBOTT LABS | 2.36% | |
| GILEAD SCIENCES INC | 2.29% | |
| INTUITIVE SURGICAL INC | 2.17% | |
| PFIZER INC | 2.11% | |
| BRISTOL-MYERS SQUIBB CO | 1.63% | |
| DANAHER CORP | 1.58% | |
| NOVO NORDISK-B | 1.54% | |
| VERTEX PHARMACEUTICALS INC | 1.50% | |
| STRYKER CORP | 1.50% | |
| GSK PLC | 1.49% | |
| MEDTRONIC PLC | 1.47% | |
| MCKESSON CORP | 1.40% | |
| Sanofi SA | 1.37% | |
| BOSTON SCIENTIFIC CORP | 1.23% | |
| CVS HEALTH CORP | 1.21% | |
| REGENERON PHARMACEUTICALS INC | 1.03% | |
| HCA HEALTHCARE INC | 0.98% | |
| THE CIGNA GROUP | 0.93% | |
| ESSILORLUXOTTICA | 0.90% | |
| ELEVANCE HEALTH INC | 0.85% | |
| CENCORA INC | 0.81% | |
| TAKEDA PHARMACEU | 0.78% | |
| HOYA CORP | 0.78% | |
| ZOETIS INC CL A | 0.66% | |
| CARDINAL HEALTH INC | 0.66% | |
| CSL LTD COMMON STOCK | 0.63% | |
| EDWARDS LIFESCIENCES CORP | 0.61% | |
| Bayer Aktiengesellschaft | 0.60% | |
| LONZA GROUP -REG | 0.60% | |
| ARGENX SE | 0.59% | |
| IDEXX LABS INC | 0.59% | |
| BECTON DICKINSON and CO | 0.59% | |
| HALEON PLC | 0.58% | |
| BlackRock Cash Funds: Institutional, SL Agency Shares | 0.55% | |
| ALCON INC | 0.50% | |
| OTSUKA HOLDINGS | 0.48% | |
| UCB SA | 0.48% | |
| GALDERMA GRP. AG | 0.48% | |
| CHUGAI PHARMA CO | 0.47% | |
| SANDOZ GROUP AG | 0.46% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.